Delivery Order SPE2DB20D2014-SPE2DB25FC62U
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,440.52 to AmerisourceBergen Drug Corp for 180 tablets of Janumet XR 50-1,000 mg, a diabetes medication combining metformin and sitagliptin. The contract was awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, and employs firm fixed pricing with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Janumet XR 50-1,000 mg tablets in a quantity of 180 units. This delivery order, valued at approximately $39,906, represents a firm fixed-price contract with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,731.43 to AmerisourceBergen Drug Corp for JANUMET XR 50-1000 (180 tablets) on September 12, 2025, with an ultimate completion date of October 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $32,272.39 to AmerisourceBergen Drug Corp for 180-count supplies of Janumet XR 50-1,000 mg tablets, a combination diabetes medication. This is a firm fixed-price, non-set-aside contract with a completion date of September 15, 2025, executed on September 12, 2025. The order is being fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $3,095.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Janumet 50-1,000 mg, a combination diabetes medication. The contract, which was not set aside and competitively awarded, was executed on September 17, 2025, with an ultimate completion date of September 18, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply delivery supporting...
- The Defense Logistics Agency awarded a delivery order valued at $2,065.75 to AmerisourceBergen Drug Corp for 180-count supplies of Janumet XR 50-1,000 mg tablets. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, ultimately completed on August 20, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the order from its corporate office location. This delivery order was issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) with a ceiling value of $19,423.78. This firm fixed-price delivery order represents a non-set-aside, competitively awarded transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX. The ultimate completion date for this delivery order is August 5,...
- The Defense Logistics Agency awarded a delivery order valued at $2,528.28 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Janumet XR 50-1,000 mg tablets in a quantity of 180 units. This competitively awarded, non-set-aside contract involves firm fixed pricing and is scheduled for completion by September 2, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- AmerisourceBergen Drug Corp received a delivery order award valued at $14,630.97 from the Defense Logistics Agency's Medical Supply Chain for 180 tablets of Janumet XR 50-1,000 mg, a combination medication used in diabetes treatment. Issued on September 11, 2025, with an ultimate completion date of September 12, 2025, this firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The award is performed at the vendor's corporate office location...
- The Defense Logistics Agency awarded a $5,726.52 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of 1,000 tablets of Janumet 50-1,000 mg, a diabetes medication combining metformin and sitagliptin. This is a firm fixed-price, non-set-aside contract with a completion date of September 15, 2025, and performance location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child order under a larger contract vehicle,...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC62UDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,202.00 for 180 tablets of Janumet XR 50-1,000 mg, a diabetes medication combining metformin and sitagliptin. Awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, this firm fixed price delivery order was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military and veteran healthcare systems. The company's contract portfolio with DLA demonstrates extensive experience fulfilling diverse medical supply requirements through competitive delivery orders with firm fixed pricing. The DLA Troop Support Medical contract vehicle represents a strategic approach to pharmaceutical procurement, supporting customers including the Defense Health Agency and U.S. Coast Guard through flexible contracting mechanisms designed to ensure reliable global pharmaceutical support for Department of Defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/1/25 |